You are here: Home: BCU 9 | 2005: Breast Cancer Journal Club Notes
 
     
 

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Romond EH et al. N Engl J Med 2005;353(16):1673-84.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ et al; Herceptin Adjuvant (HERA) Trial Study Team. N Engl J Med 2005;353(16):1659-72.
E2100: A randomized Phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer.
Miller KD et al. Presentation. ASCO 2005.
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.
Bajetta E et al. J Clin Oncol 2005;23(10):2155-61.
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma. A prospectively planned combined survival analysis of two multicenter trials.
Howell A et al. Cancer 2005;104:236-9.
Patterns of care in medical oncology: A case survey comparing practices of breast cancer investigators and general oncologists: Section 1 — Adjuvant Endocrine Therapy.
Love N. Patterns of Care in Medical Oncology 2005;2(3).
 

 

 

 

 

 

 

 

 

 

  
 
 
     
 
 


 
Editor’s Note:
Cheetos and raisins for dinner: The curse of Wilma and why a public sector that can’t figure out a way to get electricity to gas stations seems unlikely to
be victorious in the “war on cancer”
 
Harold J Burstein, MD, PhD
- Select publications
 
Charles L Vogel, MD
- Select publications
 
Eleftherios P Mamounas, MD, MPH
- Select publications
 
Journal Club

Breast Cancer Journal Club Notes

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Trastuzumab After Adjuvant Chemotherapy in HER2-Positive Breast Cancer

E2100: A Randomized Phase III Trial of Paclitaxel versus Paclitaxel Plus Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer

Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer (ABC) in Older Women

Fulvestrant versus Anastrozole for the Treatment of Advanced
Breast Carcinoma: A Prospectively Planned Combined Survival
Analysis of Two Multicenter Trials

Patterns of Care in Medical Oncology: A Case Survey Comparing Practices of Breast Cancer Investigators and General Oncologists — Section A: Adjuvant Endocrine Therapy

 
 
CME Information
Faculty Disclosures
Editor's Office